DBT- BIRAC research consortium recommends 70 proposals for funding in Vaccines, Diagnostics, Therapeutics & other Technologies

<span style="color: #222222;">Department of Biotechnology and Biotechnology Industry Research Assistance Council (DBT – BIRAC) research consortium has recommended 70 proposals for funding in Vaccines, Diagnostics, Therapeutics and other Technologies. The shortlisted proposals includes ten Vaccines candidates, 34 Diagnostics products, ten Therapeutics options, two proposals on Drug Repurposing and 14 projects which are categorized as preventive interventions.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Science and Technology Ministry said, to urgently develop safe and effective Biomedical solutions against SARS CoV-2, DBT- BIRAC had invited applications for COVID-19 Research Consortium. In addition, BIRAC has also created a provision to fund COVID-19 solutions that are ready for immediate deployment under a fast track review process. Through this initiative Start ups with PPE solutions have been approved for supporting manufacturing of Full body coverage suits to Aarna Biomedical Products and for Face Shields to Alpha Corpusles Private limited.</span><br />” &nbsp;<br />

Most Read
View All arrow-right

No posts found.